Señales en vivo de 002932.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 03:04):

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally...

Stats
Volumen de hoy	5.04M
Volumen promedio	4.26M
Capitalización de mercado	4.83B
EPS	CNY0 ( 2023-10-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	63.00
ATR14	CNY0.0170 (0.08%)

Volumen Correlación

Largo: -0.12 (neutral)

Corto: -0.98 (very strong negative)

Signal:(48.391) Neutral

Wuhan Easy Diagnosis Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Wuhan Easy Diagnosis Correlación - Moneda/Commodity

-0.58
( weak negative )

-0.71
( moderate negative )

0.00
( neutral )

-0.54
( weak negative )

0.49
( neutral )

0.53
( weak )

Wuhan Easy Diagnosis Finanzas

Annual	2023
Ingresos:	CNY749.54M
Beneficio Bruto:	CNY406.83M (54.28 %)
EPS:	CNY0.330

FY	2023
Ingresos:	CNY749.54M
Beneficio Bruto:	CNY406.83M (54.28 %)
EPS:	CNY0.330

FY	2022
Ingresos:	CNY10.53B
Beneficio Bruto:	CNY7.04B (66.85 %)
EPS:	CNY18.08

FY	2021
Ingresos:	CNY2.83B
Beneficio Bruto:	CNY2.12B (75.02 %)
EPS:	CNY14.84

Financial Reports:

No articles found.

Wuhan Easy Diagnosis

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.